Aliyu Maryam Muhammad, Nasir Idris Abdullahi, Umar Yahaya Abdullahi, Vanstawa Anthony Philip, Medugu Jessy Thomas, Emeribe Anthony Uchenna, Amadu Dele Ohinoyi
Department of Biological Science, National Defense Academy, Kaduna State, Nigeria.
Department of Medical Laboratory Services, University of Abuja Teaching Hospital, Gwagwalada, Federal Capital Territory, Abuja, Nigeria.
Tzu Chi Med J. 2017 Apr-Jun;29(2):98-103. doi: 10.4103/tcmj.tcmj_22_17.
Pregnant women infected with malaria represent a significant obstetric problem, especially in the face of antimalarial resistance. This cross-sectional study investigated the prevalence of malaria parasitemia, associated risk factors as well as the antimalarial resistance pattern of isolates from pregnant women attending four selected secondary health facilities in Kaduna State, Nigeria.
Blood samples were collected from 353 pregnant women attending selected hospitals. Malaria microscopy and parasite density count were conducted based on standard protocols. Antimalarial susceptibility test (using chloroquine, artesunate, artether, and sulfadoxine-pyrimethamine), and hemoglobin concentrations were determined using schizont maturation assay and methemoglobin method, respectively. Multiple-drug resistance (MDR) was defined by resistance against ≥3 antimalarial drugs.
The overall prevalence of plasmodiasis was 22.4%. Out of those infected, 5.2% was found to be anemic. Malaria parasitemia was significantly associated with parity, residential area, age of women, and use of preventive measures against malaria ( < 0.05) but not with hemoglobin concentration, occupation, and trimester of pregnancy ( > 0.05). Malaria parasites from the pregnant women exhibited the highest resistance against chloroquine, 75 (94.9%) followed Artemether, 30 (37.9%) then sulfadoxine-pyrimethamine, 29 (36.7%) and least resistant to artesunate, 28 (35.4%). The prevalence of MDR was 40.5% (32/79).
The prevalence of malaria was relatively high due to inadequate and/or ineffective preventive measures adopted by pregnant women. More so, significant isolates of exhibited MDR against antimalarial agents tested.
感染疟疾的孕妇是一个重大的产科问题,尤其是面对抗疟药物耐药性时。这项横断面研究调查了尼日利亚卡杜纳州四家选定二级卫生设施中就诊的孕妇疟疾寄生虫血症的患病率、相关危险因素以及分离株的抗疟耐药模式。
从选定医院的353名孕妇中采集血样。根据标准方案进行疟疾显微镜检查和寄生虫密度计数。分别使用裂殖体成熟试验和高铁血红蛋白法进行抗疟药敏试验(使用氯喹、青蒿琥酯、蒿甲醚和磺胺多辛-乙胺嘧啶)以及测定血红蛋白浓度。多重耐药性(MDR)定义为对≥3种抗疟药物耐药。
疟原虫病的总体患病率为22.4%。在这些感染者中,发现5.2%患有贫血。疟疾寄生虫血症与产次、居住地区、女性年龄以及使用疟疾预防措施显著相关(P<0.05),但与血红蛋白浓度、职业和妊娠 trimester 无关(P>0.05)。孕妇的疟原虫对氯喹的耐药性最高,75例(94.9%),其次是蒿甲醚,30例(37.9%),然后是磺胺多辛-乙胺嘧啶,29例(36.7%),对青蒿琥酯的耐药性最低,28例(35.4%)。多重耐药的患病率为40.5%(32/79)。
由于孕妇采取的预防措施不足和/或无效,疟疾患病率相对较高。此外,分离株对所测试的抗疟药物表现出显著的多重耐药性。